✦ LIBER ✦

Multifaceted perspective of the waiting list for liver transplantation: The value of pharmacokinetic models

✍ Scribed by Miquel Navasa; Jordi Bruix

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 148 KB
Volume: 51
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.23332

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Removing patients from the liver transpl

Removing patients from the liver transplant wait list: A survey of US liver transplant programs

✍ Kevin P. Charpentier; Arun Mavanur 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB

Guidelines are in place regarding who is a candidate for liver transplantation. Once a potential candidate is listed, there are no uniform guidelines indicating when he should be removed from the list because of a change in clinical status. A survey with 14 scenarios was sent to the medical and surg

The perspective of liver transplantation

The perspective of liver transplantation for cholangiocarcinoma

✍ Sven Jonas; Peter Neuhaus 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Transplantation for hepatocellular carci

Transplantation for hepatocellular carcinoma: Management of patients on the waiting list

✍ Pietro Majno; Gilles Mentha; Christian Toso; for the Geneva Liver Cancer Study G 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

In discussing the mananagement of patients in the waiting list, the terms neoadjuvant treatment, bridging, downstaging and dropout should be used consistently, and on the basis of accepted selection criteria (currently MC, incorporated into the tumor-nodemetastasis [TNM] staging system as follows: T

Deaths on the liver transplant waiting l

Deaths on the liver transplant waiting list: An analysis of competing risks

✍ W. Ray Kim; Terry M. Therneau; Joanne T. Benson; Walter K. Kremers; Charles B. R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

The usual method of estimating survival probabilities, namely the Kaplan-Meier method, is suboptimal in the analysis of deaths on the transplant waiting list. Death, transplantation, and withdrawal from list must all be considered. In this analysis, we applied the competing risk analysis method, whi

Management of hepatocellular carcinoma o

Management of hepatocellular carcinoma on the waiting list before liver transplantation: Time for controlled trials?

✍ Pietro Majno; Emiliano Giostra; Gilles Mentha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Francisco; RFTA, radiofrequency thermal ablation; TACE, transarterial chemoembolization; UNOS, United Network for Organ Sharing. This article is based on a review of the treatment of hepatocellular carcinoma while patients are on a liver transplant waiting list that our group published in Journal of

Gender disparity in liver transplant wai

Gender disparity in liver transplant waiting-list mortality: The importance of kidney function

✍ Ayse L. Mindikoglu; Arie Regev; Stephen L. Seliger; Laurence S. Magder 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB

Previous studies of men and women on the liver transplantation (LT) waiting list, without taking transplantation rates into account, have suggested a higher risk of mortality for women on the waiting list. The objective of this study was to compare men and women with respect to dying within 3 years